Data spanning the past 90 days through December 12, 2025 reveals that Insight Molecular Diagnostics's three principal insider shareholders consist of Chief Financial Officer Andrea S. James (189.06K shares), Director Andrew J. Last (39.51K shares), Director John Peter Gutfreund (35.75K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Partners, L.P. Broadwood | 11,410,100 | 10 Feb, 2025 | |
| Vida Investments, Llc Pura | 404,510 | 07 Apr, 2023 | |
| Patrick W Smith | 3,258,485 | 11 Feb, 2025 | |
| John Peter Gutfreund | 35,750 | 05 Apr, 2023 | |
| Ronald Asbury Andrews | Former CEO | 29,161 | 09 Dec, 2022 |
| Alfred D Kingsley | 24,456 | 27 Jun, 2023 | |
| Gisela Paulsen | Former President And COO | 18,325 | 20 Dec, 2022 |
| Andrew Arno | 144,358 | 03 Jul, 2025 | |
| Douglas T. Ross | Former Cso | 11,706 | 22 Dec, 2022 |
| Andrea S. James | Chief Financial Officer | 189,056 | 13 Nov, 2025 |
| Anish M. John | Chief Financial Officer | 7,500 | 17 Aug, 2022 |
| Cavan M. Redmond | 6,043 | 19 Jul, 2022 | |
| Mitchell S Levine | Chief Financial Officer | 4,354 | 15 Mar, 2022 |
| Andrew J. Last | 39,509 | 03 Jul, 2025 | |
| Lou Silverman | 36,564 | 03 Jul, 2025 | |
| Jennifer L. Carter | 1,525 | 17 Aug, 2022 | |
| Melinda Griffith | 1,500 | 17 Aug, 2022 | |
| Li Yu | VP Cntrllr/Prncpl Acctng Offcr | 844 | 19 May, 2022 |
| Josh Riggs | CEO And President | 3,505 | 15 Apr, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 31 Oct, 2025 | Andrea S. James | Common Stock | A | 50,000 | $0.00 | 201,231 | D | M |
| 31 Oct, 2025 | Andrea S. James | Common Stock | A | 50,000 | $0.00 | 201,231 | D | M |
| 31 Oct, 2025 | Andrea S. James | Common Stock | D | 12,175 | $6.01 | 189,056 | D | F |
| 01 Jul, 2025 | Lou Silverman | Common Stock, no par value | A | 35,000 | $0.00 | 36,564 | D | A |
| 01 Jul, 2025 | Andrew Arno | - | - | 136,554 | D | |||
| 01 Jul, 2025 | Andrew J. Last | Common Stock, no par value | A | 35,000 | $0.00 | 39,509 | D | A |
| 01 Jul, 2025 | Andrew Arno | Common Stock, no par value | A | 55,000 | $0.00 | 136,554 | D | A |
| 07 Feb, 2025 | Andrea S. James | - | - | 151,231 | D | |||
| 07 Feb, 2025 | Andrea S. James | Common Stock, no par value | A | 97,561 | $2.05 | 151,231 | D | P |
| 07 Feb, 2025 | Patrick W Smith | Common Stock, no par value | A | 1,077,600 | $2.05 | 2,872,671 | I | P |
| 07 Feb, 2025 | Patrick W Smith | Common Stock, no par value | A | 385,814 | $2.05 | 3,258,485 | I | J |
| 06 Feb, 2025 | Partners, L.P. Broadwood | - | - | 6,904,612 | D | |||
| 06 Feb, 2025 | Partners, L.P. Broadwood | Common Stock, no par value | A | 660,207 | $2.05 | 6,904,612 | D | P |
| 06 Feb, 2025 | Partners, L.P. Broadwood | - | - | 11,410,100 | D | |||
| 06 Feb, 2025 | Partners, L.P. Broadwood | Common Stock, no par value | A | 4,505,488 | $2.05 | 11,410,100 | D | P |
| 31 Jan, 2025 | Patrick W Smith | Common Stock, no par value | A | 890 | $2.01 | 1,795,046 | I | P |
| 04 Feb, 2025 | Patrick W Smith | Common Stock, no par value | A | 25 | $2.02 | 1,795,071 | I | P |
| 29 Jan, 2025 | Patrick W Smith | Common Stock, no par value | A | 3,880 | $2.01 | 1,793,838 | I | P |
| 30 Jan, 2025 | Patrick W Smith | Common Stock, no par value | A | 318 | $2.01 | 1,794,156 | I | P |
| 13 Jan, 2025 | Patrick W Smith | Common Stock, no par value | A | 5,669 | $2.08 | 1,779,572 | I | P |